Clinical Trials Logo

Diabetic Foot Ulcer clinical trials

View clinical trials related to Diabetic Foot Ulcer.

Filter by:

NCT ID: NCT01623882 Withdrawn - Diabetic Foot Ulcer Clinical Trials

Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System

OG/SNaP
Start date: June 2012
Phase:
Study type: Observational

The primary purpose of this study is to evaluate the safety and efficacy of the concurrent use of Apligraf® and the SNaP® Wound Care System for the treatment of diabetic and venous stasis lower extremity ulcers.

NCT ID: NCT00338702 Withdrawn - Diabetic Foot Ulcer Clinical Trials

A Randomized, Controlled Trial of Autologous Platelet Gel Treatment in Diabetic Foot Ulcers

Start date: March 2008
Phase: Phase 4
Study type: Interventional

Foot ulcers represent a significant common complication in patients with diabetes. Wound healing is a challenge. Some wounds do not respond to the best practices in wound care. Considerable effort has been directed at therapies to improve the rate of healing. There are a variety of growth factors which have been used to stimulate wound healing. Human platelets are an autologous source of growth factors which probably can stimulate healing. Autologous platelet gel (APG) is prepared by centrifugation of autologous human whole blood. APG is rich in platelet growth factors. This study will investigate the potential improvement in wound healing with this material in diabetic foot ulcers. This study will compare the use of autologous platelet gel ( study group) and standard care ( control group) in the treatment of diabetic plantar forefoot ulcers. This study will also compare the cost and quality of life in the two groups. Objectives of the study: - To determine if topical APG (autologous platelet gel) is beneficial in the treatment of diabetic foot ulcers. - To determine if it will result in a faster rate of wound healing. - To determine if it will improve the quality of life in patients with diabetic foot ulcers.